Aardvark Therapeutics Inc (AARD) Stock Price, Quote, News & History

AARDNASDAQ
$5.23
Last update: Apr 17, 4:00 PM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-54.17M
Investing Cash Flow (TTM)
-49.67M
Financing Cash Flow (TTM)
89.25M
Free Cash Flow (TTM)
-54.27M
Capital Expenditure (TTM)
-95.00K
Net Change in Cash (TTM)
-14.59M

Analyst Trends and Forecast

2
Nov 25
2
Dec 25
2
Feb
3
2
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$4.51M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.07
Earnings Yield % (TTM)
-56.02%
Earnings Yield % (FWD)
-66.54%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$4.89

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$47.05M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$5.16
Close
-
Volume / Avg.
80.31K / 287.53K
Day Range
$5.16 - $5.48
52 Wk Range
3.35 - 17.94
Market Cap
$114.10M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
55
Short Interest
7.86%
Days to Cover
3.79

About

Sector
Health Care
Industry
Pharmaceuticals
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Aardvark Therapeutics (AARD) stock?

A

You can purchase shares of Aardvark Therapeutics (NASDAQ:AARD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aardvark Therapeutics (AARD) competitors?

Q

What is the forecast, or price target, for Aardvark Therapeutics (AARD) stock?

A

Aardvark Therapeutics has a consensus price target of $19.63.

Q

What is the current price for Aardvark Therapeutics (AARD)?

A

The stock price for Aardvark Therapeutics (NASDAQ: AARD) is $5.23 last updated April 17, 2026 at 4:00 PM EDT.

Q

Does Aardvark Therapeutics (AARD) pay a dividend?

A

There are no upcoming dividends for Aardvark Therapeutics.

Q

When is Aardvark Therapeutics (NASDAQ:AARD) reporting earnings?

A

Aardvark Therapeutics does not have any upcoming earnings scheduled.

Q

Is Aardvark Therapeutics (AARD) going to split?

A

There is no upcoming split for Aardvark Therapeutics.

Q

What sector and industry does Aardvark Therapeutics (AARD) operate in?

A

Aardvark Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.